Alcon fails in defence vs AMO (Advanced Medical Optics) in patent dispute but gains stay of injunction
This article was originally published in Clinica
Executive Summary
Shares in Alcon fell $6.89, or 5%, to hit $130.68 during mid-morning trading at the beginning of the week after a judge upheld a patent infringement charge by Advanced Medical Optics (AMO) and ordered Alcon to pay its rival $213.9m in damages.